Robert A. Cascella's most recent trade in Neuronetics Inc was a trade of 36,250 Common Stock done . Disclosure was reported to the exchange on May 22, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Neuronetics Inc | Robert A. Cascella | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2025 | 36,250 | 578,236 (3%) | 0% | - | Common Stock | |
| Mirion Technologies Inc. -... | Robert A. Cascella | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2025 | 7,977 | 53,418 | - | 0 | Class A Common Stock | |
| KORU Medical Systems Inc | Robert A. Cascella | Director | Grant, award, or other acquisition of securities at price $ 2.56 per share. | 02 Apr 2025 | 5,870 | 80,426 (0%) | 0% | 2.6 | 15,027 | Common Stock |
| Celestica, Inc. | Robert A. Cascella | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2025 | 468 | 468 | - | - | Restricted Share Units | |
| Neuronetics Inc | Robert A. Cascella | Director | Other type of transaction at price $ 2.25 per share. | 07 Feb 2025 | 88,888 | 541,986 (2%) | 0% | 2.3 | 199,998 | Common Stock |
| KORU Medical Systems Inc | Robert A. Cascella | Director | Grant, award, or other acquisition of securities at price $ 3.81 per share. | 03 Jan 2025 | 3,937 | 74,556 (0%) | 0% | 3.8 | 15,000 | Common Stock |
| Celestica, Inc. | Robert A. Cascella | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2024 | 419 | 73,793 | - | - | Deferred Share Units | |
| KORU Medical Systems Inc | Robert A. Cascella | Director | Grant, award, or other acquisition of securities at price $ 2.75 per share. | 01 Oct 2024 | 5,454 | 70,978 (0%) | 0% | 2.8 | 14,999 | Common Stock |
| KORU Medical Systems Inc | Robert A. Cascella | Director | Grant, award, or other acquisition of securities at price $ 2.75 per share. | 01 Oct 2024 | 5,454 | 70,619 (0%) | 0% | 2.8 | 14,999 | Common Stock |
| Neuronetics Inc | Robert A. Cascella | Director | Purchase of securities on an exchange or from another person at price $ 0.75 per share. | 12 Sep 2024 | 100,000 | 453,098 (2%) | 0% | 0.8 | 75,000 | Common Stock |
| Neuronetics Inc | Robert A. Cascella | Director | Purchase of securities on an exchange or from another person at price $ 1.06 per share. | 16 Aug 2024 | 35,000 | 349,098 (1%) | 0% | 1.1 | 37,100 | Common Stock |
| Neuronetics Inc | Robert A. Cascella | Director | Purchase of securities on an exchange or from another person at price $ 1.14 per share. | 16 Aug 2024 | 4,000 | 353,098 (1%) | 0% | 1.1 | 4,560 | Common Stock |
| Neuronetics Inc | Robert A. Cascella | Director | Purchase of securities on an exchange or from another person at price $ 0.88 per share. | 14 Aug 2024 | 35,000 | 314,098 (1%) | 0% | 0.9 | 30,800 | Common Stock |
| Neuronetics Inc | Robert A. Cascella | Director | Purchase of securities on an exchange or from another person at price $ 0.79 per share. | 14 Aug 2024 | 35,000 | 279,098 (1%) | 0% | 0.8 | 27,650 | Common Stock |
| KORU Medical Systems Inc | Robert A. Cascella | Director | Grant, award, or other acquisition of securities at price $ 2.71 per share. | 11 Jul 2024 | 5,545 | 65,524 (0%) | 0% | 2.7 | 15,027 | Common Stock |
| KORU Medical Systems Inc | Robert A. Cascella | Director | Grant, award, or other acquisition of securities at price $ 2.71 per share. | 11 Jul 2024 | 5,545 | 65,165 (0%) | 0% | 2.7 | 15,027 | Common Stock |
| Neuronetics Inc | Robert A. Cascella | Director | Purchase of securities on an exchange or from another person at price $ 2.05 per share. | 06 Jun 2024 | 50,000 | 244,098 (1%) | 0% | 2.1 | 102,550 | Common Stock |
| Mirion Technologies Inc. -... | Robert A. Cascella | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 13,500 | 45,441 | - | 0 | Class A Common Stock | |
| Neuronetics Inc | Robert A. Cascella | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 31,250 | 194,098 (1%) | 0% | - | Common Stock | |
| KORU Medical Systems Inc | Robert A. Cascella | Director | Grant, award, or other acquisition of securities at price $ 2.37 per share. | 31 Mar 2024 | 6,329 | 59,620 (0%) | 0% | 2.4 | 15,000 | Common Stock |
| KORU Medical Systems Inc | A. Robert Cascella | Director | Grant, award, or other acquisition of securities at price $ 2.37 per share. | 31 Dec 2023 | 6,329 | 53,291 (0%) | 0% | 2.4 | 15,000 | Common Stock |
| KORU Medical Systems Inc | Robert A. Cascella | Director | Purchase of securities on an exchange or from another person at price $ 2.61 per share. | 16 Aug 2023 | 19,000 | 41,478 (0%) | 0% | 2.6 | 49,533 | Common Stock |
| KORU Medical Systems Inc | Robert A. Cascella | Director | Grant, award, or other acquisition of securities at price $ 3.48 per share. | 30 Jun 2023 | 4,310 | 22,478 (0%) | 0% | 3.5 | 14,999 | Common Stock |
| Mirion Technologies Inc. -... | Robert A. Cascella | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 11,850 | 31,941 | - | 0 | Class A Common Stock | |
| Neuronetics Inc | Robert A. Cascella | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 45,455 | 134,348 (0%) | 0% | - | Common Stock | |
| KORU Medical Systems Inc | Robert A. Cascella | Director | Grant, award, or other acquisition of securities at price $ 4.26 per share. | 31 Mar 2023 | 3,521 | 18,168 (0%) | 0% | 4.3 | 14,999 | Common Stock |
| KORU Medical Systems Inc | Robert A. Cascella | Director | Grant, award, or other acquisition of securities at price $ 3.51 per share. | 31 Dec 2022 | 4,273 | 14,647 (0%) | 0% | 3.5 | 14,998 | Common Stock |
| KORU Medical Systems Inc | Robert A. Cascella | Director | Grant, award, or other acquisition of securities at price $ 2.25 per share. | 30 Sep 2022 | 6,681 | 3,693 (0%) | 0% | 2.2 | 15,032 | Common Stock |
| KORU Medical Systems Inc | Robert A. Cascella | Director | Grant, award, or other acquisition of securities at price $ 2.50 per share. | 30 Jun 2022 | 3,693 | 3,693 (0%) | 0% | 2.5 | 9,233 | Common Stock |
| Mirion Technologies Inc. -... | Robert A. Cascella | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 14,274 | 20,091 | - | 0 | Common Stock | |
| Neuronetics Inc | Robert A. Cascella | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 48,638 | 88,893 (0%) | 0% | - | Common Stock | |
| Mirion Technologies Inc. -... | Robert A. Cascella | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Dec 2021 | 5,817 | 5,817 | - | 0 | Common Stock | |
| Neuronetics Inc | Robert A. Cascella | Director | Purchase of securities on an exchange or from another person at price $ 4.10 per share. | 22 Nov 2021 | 15,000 | 40,255 (0%) | 0% | 4.1 | 61,497 | Common Stock |
| Neuronetics Inc | Robert A. Cascella | Director | Purchase of securities on an exchange or from another person at price $ 6.72 per share. | 30 Aug 2021 | 15,000 | 25,255 (0%) | 0% | 6.7 | 100,850 | Common Stock |
| Neuronetics Inc | Robert A. Cascella | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2021 | 8,922 | 10,255 (0%) | 0% | - | Common Stock | |
| Neuronetics Inc | Robert A. Cascella | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2021 | 1,333 | 1,333 (0%) | 0% | - | Common Stock |